PennsylvaniaHB 19452025-2026 Regular SessionHouse

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Sponsored By: Paul Friel (Democratic)

First Reading

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Paul Friel

    Democratic • House

Cosponsors

  • Arvind Venkat

    Democratic • House

  • Ben Waxman

    Democratic • House

  • Benjamin V. Sanchez

    Democratic • House

  • Carol Hill-Evans

    Democratic • House

  • Lindsey Marie Williams

    Democratic • Senate

  • Danilo Burgos

    Democratic • House

  • Doyle Heffley

    Republican • House

  • Ed Neilson

    Democratic • House

  • Emily Kinkead

    Democratic • House

  • Arthur L Haywood III

    Democratic • Senate

  • Kristine C. Howard

    Democratic • House

  • La'Tasha D. Mayes

    Democratic • House

  • Liz Hanbidge

    Democratic • House

  • Marla Brown

    Republican • House

  • Tarik Khan

    Democratic • House

  • Valerie S. Gaydos

    Republican • House

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Laid on the table

    4/27/2026House
  2. First consideration

    4/27/2026House
  3. Reported as committed

    4/27/2026House
  4. Referred to Judiciary

    10/16/2025House

Bill Text

Related Bills

Back to State Legislation